Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOXIDOSE: Moxidectin and Moxidectin-albendazole for Trichuris Trichiura in Adolescents
NCT03501251Phase 2Completed
- Sponsor
- Swiss Tropical and Public Health Institute
- Start
- Jul 2018
- Primary completion
- Aug 2018
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 2, randomised trial of moxidectin in trichuriasis (7 arms), sponsored by Swiss Tropical and Public Health Institute. Primary endpoint: Cure rate against Trichuris trichiura at 6 weeks. Started Jul 2018; status: completed.
02
Drugs
moxidectin
03
Conditions
trichuriasis
Beyond the preview
Go deeper on NCT03501251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03501251.